68 results
8-K
EX-99.1
VTAK
Catheter Precision Inc.
18 Apr 23
Ra Medical Announces Resignation of CEO
6:04pm
and contributions and wishes him the best in future endeavors.
The RMED board of directors, as part of its governance commitment, last month established
8-K
EX-99.1
VTAK
Catheter Precision Inc.
16 Aug 21
Ra Medical Systems Announces Sale of Pharos Dermatology Business
4:55pm
is focused on the therapeutic dermatology market with a commitment to individuals with chronic skin conditions. We have valued our relationships
10-Q
2018 Q3
EX-10.2
VTAK
Catheter Precision Inc.
14 Nov 18
Quarterly report
12:00am
will not in any way utilize any such information. By signing this Agreement , you confirm that you have no contractual commitment s or other legal obligations
8-K
VTAK
Catheter Precision Inc.
9 Feb 22
Ra Medical Systems, Inc. Announces Pricing of $12.0 Million Underwritten Public Offering
12:00am
commitment underwritten public offering by the Company (the “Public Offering”), (i) 9,535,000 units, priced at a public offering price of $0.50 per unit
8-K
EX-99.1
36v1 rtlyf3sa5
16 May 23
Ra Medical Systems Provides First Corporate Update Since Merger
4:16pm
8-K/A
shpxo90
2 Sep 22
Entry into a Material Definitive Agreement
5:29pm
8-K
EX-99.1
fs6xv
15 Aug 22
Ra Medical Systems Reports Second Quarter 2022 Financial Results
5:49pm
DRS/A
EX-10.1
zywbo35qzbxj8
28 Jun 18
Draft registration statement (amended)
12:00am
S-1
EX-10.1
wnnt28ey4rm 31yp2env
16 Jul 18
IPO registration
5:13pm
8-K
8u9mqhiwauwgag7
22 Jul 22
Entry into a Material Definitive Agreement
8:35am
8-K
EX-10.1
yeq2qb
9 Sep 22
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
8:12pm
S-1
EX-10.7
m1uf2vt
16 Jul 18
IPO registration
5:13pm
DRS/A
EX-10.7
hz2v 64de12u001e
28 Jun 18
Draft registration statement (amended)
12:00am
8-K
EX-2.1
qll5q5m
9 Sep 22
Ra Medical Systems Enters Into Definitive Merger Agreement with Catheter Precision
8:12pm
424B5
xfoytn0
2 Sep 22
Prospectus supplement for primary offering
5:17pm
10-K
np4e42
15 Mar 19
Annual report
12:00am
DRS
dc8cr
21 May 18
Draft registration statement
12:00am
S-3
EX-1.2
s17k7
26 Jan 21
Shelf registration
4:13pm